Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference
September 06, 2023 08:00 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a medical technology company that creates blood purification...
Sigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific Officer
April 11, 2023 08:30 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, April 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY) (“Sigyn Therapeutics” or the “Company”), a development-stage company focused on the...
Sigyn Therapeutics Appoints Donald J. Hillebrand, M.D. to its Scientific Advisory Board
April 26, 2022 08:00 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on the treatment of pathogen-associated...
The Evolution of Blood Purification Technologies to Treat Emerging Pandemic Threats, Including COVID-19
June 28, 2021 09:30 ET
|
Sigyn Therapeutics, Inc.
Webinar Event to Be Held Tomorrow June 29th at 12pm Eastern / 9am Pacific Time SAN DIEGO, CA, June 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a...